Sterling Pharma: A versatile CDMO you can depend on; Sterling combines a full-service offering with expert knowledge and technical agility to offer API development and cGMP contract manufacturing capabilities. They can support your projects through the entire product lifecycle from grams to tons.Their 700+ strong team across our facilities in the UK and the US are capable of handling even the most hazardous chemical processes safely. Industry-leading compliance culture and performance are part of their day-to-day work, and they work hard to maintain the Sterling standards.Dedicated to adding value through continuous improvement, they constantly explore new and improved ways of doing things as part of their Technology and Innovation Program.With over 50 years of experience, their exceptionally talented team combines their unrivaled knowledge with first-class customer service to ensure high-quality project delivery every time. That’s the Sterling way!
Bio Highlights: Dr. Till Riehm is Executive Vice President and Site Head at Sterling Pharma Solutions in Germantown, Wisconsin, where he leads operations for the company’s pharmaceutical CDMO site focused on API and highly potent API synthesis. He brings extensive global leadership experience across pharmaceutical manufacturing, CDMO operations, fine chemicals, biotechnology, and specialty materials.
Prior to joining Sterling, Dr. Riehm served as General Manager of Hovione Eireann in Cork, Ireland, overseeing API synthesis and spray drying operations. He also held multiple leadership roles within International Chemical Investors Group, including Managing Director of Allessa GmbH and Corden BioChem, where he led multi-site operations, turnaround efforts, commercial strategy, and operational excellence initiatives. Dr. Riehm holds an Executive MBA from Mannheim Business School and earned his PhD in Chemistry from the University of Heidelberg, graduating summa cum laude.